UnitedHealth Group issued a 2025 outlook that missed Wall Street's expectations, according to CNBC. It projected at least $16 in adjusted EPS and up to $448 billion in revenue, both below analyst estimates. The company’s shares dropped more than 3% in premarket trading on Tuesday following the news. Insurers have faced higher Medicare Advantage costs as seniors resume delayed procedures after the COVID-19 pandemic. The report follows a string of setbacks, including the former CEO’s murder, a major cyberattack, DOJ investigations, and ongoing scrutiny over Medicare billing. Shares have plunged more than 44% this year as the company works to stabilize investor confidence.
